Cargando…

Prevalence of lifetime self-injurious thoughts and behaviors in a global sample of 599 patients reporting prospectively confirmed diagnosis with premenstrual dysphoric disorder

BACKGROUND: Suicide is the second leading cause of death among Americans ages 10 to 34, with alarming recent increases in suicide rates among those assigned female at birth. A large body of evidence points to menstrual cycle influences on self-injurious thoughts and behaviors (STBs), suggesting that...

Descripción completa

Detalles Bibliográficos
Autores principales: Eisenlohr-Moul, Tory, Divine, Madeline, Schmalenberger, Katja, Murphy, Laura, Buchert, Brett, Wagner-Schuman, Melissa, Kania, Alyssa, Raja, Sabina, Miller, Adam Bryant, Barone, Jordan, Ross, Jaclyn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8933886/
https://www.ncbi.nlm.nih.gov/pubmed/35303811
http://dx.doi.org/10.1186/s12888-022-03851-0
_version_ 1784671753641918464
author Eisenlohr-Moul, Tory
Divine, Madeline
Schmalenberger, Katja
Murphy, Laura
Buchert, Brett
Wagner-Schuman, Melissa
Kania, Alyssa
Raja, Sabina
Miller, Adam Bryant
Barone, Jordan
Ross, Jaclyn
author_facet Eisenlohr-Moul, Tory
Divine, Madeline
Schmalenberger, Katja
Murphy, Laura
Buchert, Brett
Wagner-Schuman, Melissa
Kania, Alyssa
Raja, Sabina
Miller, Adam Bryant
Barone, Jordan
Ross, Jaclyn
author_sort Eisenlohr-Moul, Tory
collection PubMed
description BACKGROUND: Suicide is the second leading cause of death among Americans ages 10 to 34, with alarming recent increases in suicide rates among those assigned female at birth. A large body of evidence points to menstrual cycle influences on self-injurious thoughts and behaviors (STBs), suggesting that neurobiological hormone sensitivities, such as in premenstrual dysphoric disorder (PMDD), may drive suicide risk in females. However, existing studies of STBs in PMDD use cross-sectional self-report measures of PMDD with poor validity. As a first step to establish accurate prevalence rates of STBs in PMDD, we examined the lifetime prevalence of STBs in a large global survey of patients reporting a diagnosis of PMDD based on daily ratings. METHOD: Individuals with self-reported PMDD symptoms were invited to an online survey through online support groups for PMDD and social media posts from PMDD awareness accounts. Participants reported demographics, whether they had been diagnosed with PMDD by a healthcare provider using daily ratings, STBs using the Columbia Suicide Severity Rating Scale, and history of lifetime comorbid psychiatric diagnoses. RESULTS: Of 2,689 survey completers, 599 (23%) reported a diagnosis with PMDD based on two months of daily ratings and were included in analyses. We observed high rates of lifetime active suicidal ideation (72%), planning (49%), intent (42%), preparing for an attempt (40%), and attempt (34%), as well as non-suicidal self-injury (51%). The majority (70%) of the sample reported at least one lifetime comorbid psychiatric diagnosis. Predictors of lifetime active suicidal ideation included nulliparity, low-to-moderate (vs. high) income, and history of diagnosis with major depression or post-traumatic stress disorder. Predictors of lifetime attempts among those reporting lifetime active ideation included older age, nulliparity, lower income, and history of diagnosis with post-traumatic stress disorder or borderline personality disorder. CONCLUSIONS: These data indicate high rates of STBs among those reporting prospective diagnosis of PMDD and highlight the need for prospective research on mechanisms and prevention of STBs in PMDD. Clinical practice guidelines for PMDD should accommodate comorbidities and recommend frequent screenings for STB risk. STBs should be considered for inclusion in future iterations of the DSM PMDD diagnostic criteria. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12888-022-03851-0.
format Online
Article
Text
id pubmed-8933886
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-89338862022-03-23 Prevalence of lifetime self-injurious thoughts and behaviors in a global sample of 599 patients reporting prospectively confirmed diagnosis with premenstrual dysphoric disorder Eisenlohr-Moul, Tory Divine, Madeline Schmalenberger, Katja Murphy, Laura Buchert, Brett Wagner-Schuman, Melissa Kania, Alyssa Raja, Sabina Miller, Adam Bryant Barone, Jordan Ross, Jaclyn BMC Psychiatry Research BACKGROUND: Suicide is the second leading cause of death among Americans ages 10 to 34, with alarming recent increases in suicide rates among those assigned female at birth. A large body of evidence points to menstrual cycle influences on self-injurious thoughts and behaviors (STBs), suggesting that neurobiological hormone sensitivities, such as in premenstrual dysphoric disorder (PMDD), may drive suicide risk in females. However, existing studies of STBs in PMDD use cross-sectional self-report measures of PMDD with poor validity. As a first step to establish accurate prevalence rates of STBs in PMDD, we examined the lifetime prevalence of STBs in a large global survey of patients reporting a diagnosis of PMDD based on daily ratings. METHOD: Individuals with self-reported PMDD symptoms were invited to an online survey through online support groups for PMDD and social media posts from PMDD awareness accounts. Participants reported demographics, whether they had been diagnosed with PMDD by a healthcare provider using daily ratings, STBs using the Columbia Suicide Severity Rating Scale, and history of lifetime comorbid psychiatric diagnoses. RESULTS: Of 2,689 survey completers, 599 (23%) reported a diagnosis with PMDD based on two months of daily ratings and were included in analyses. We observed high rates of lifetime active suicidal ideation (72%), planning (49%), intent (42%), preparing for an attempt (40%), and attempt (34%), as well as non-suicidal self-injury (51%). The majority (70%) of the sample reported at least one lifetime comorbid psychiatric diagnosis. Predictors of lifetime active suicidal ideation included nulliparity, low-to-moderate (vs. high) income, and history of diagnosis with major depression or post-traumatic stress disorder. Predictors of lifetime attempts among those reporting lifetime active ideation included older age, nulliparity, lower income, and history of diagnosis with post-traumatic stress disorder or borderline personality disorder. CONCLUSIONS: These data indicate high rates of STBs among those reporting prospective diagnosis of PMDD and highlight the need for prospective research on mechanisms and prevention of STBs in PMDD. Clinical practice guidelines for PMDD should accommodate comorbidities and recommend frequent screenings for STB risk. STBs should be considered for inclusion in future iterations of the DSM PMDD diagnostic criteria. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12888-022-03851-0. BioMed Central 2022-03-19 /pmc/articles/PMC8933886/ /pubmed/35303811 http://dx.doi.org/10.1186/s12888-022-03851-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Eisenlohr-Moul, Tory
Divine, Madeline
Schmalenberger, Katja
Murphy, Laura
Buchert, Brett
Wagner-Schuman, Melissa
Kania, Alyssa
Raja, Sabina
Miller, Adam Bryant
Barone, Jordan
Ross, Jaclyn
Prevalence of lifetime self-injurious thoughts and behaviors in a global sample of 599 patients reporting prospectively confirmed diagnosis with premenstrual dysphoric disorder
title Prevalence of lifetime self-injurious thoughts and behaviors in a global sample of 599 patients reporting prospectively confirmed diagnosis with premenstrual dysphoric disorder
title_full Prevalence of lifetime self-injurious thoughts and behaviors in a global sample of 599 patients reporting prospectively confirmed diagnosis with premenstrual dysphoric disorder
title_fullStr Prevalence of lifetime self-injurious thoughts and behaviors in a global sample of 599 patients reporting prospectively confirmed diagnosis with premenstrual dysphoric disorder
title_full_unstemmed Prevalence of lifetime self-injurious thoughts and behaviors in a global sample of 599 patients reporting prospectively confirmed diagnosis with premenstrual dysphoric disorder
title_short Prevalence of lifetime self-injurious thoughts and behaviors in a global sample of 599 patients reporting prospectively confirmed diagnosis with premenstrual dysphoric disorder
title_sort prevalence of lifetime self-injurious thoughts and behaviors in a global sample of 599 patients reporting prospectively confirmed diagnosis with premenstrual dysphoric disorder
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8933886/
https://www.ncbi.nlm.nih.gov/pubmed/35303811
http://dx.doi.org/10.1186/s12888-022-03851-0
work_keys_str_mv AT eisenlohrmoultory prevalenceoflifetimeselfinjuriousthoughtsandbehaviorsinaglobalsampleof599patientsreportingprospectivelyconfirmeddiagnosiswithpremenstrualdysphoricdisorder
AT divinemadeline prevalenceoflifetimeselfinjuriousthoughtsandbehaviorsinaglobalsampleof599patientsreportingprospectivelyconfirmeddiagnosiswithpremenstrualdysphoricdisorder
AT schmalenbergerkatja prevalenceoflifetimeselfinjuriousthoughtsandbehaviorsinaglobalsampleof599patientsreportingprospectivelyconfirmeddiagnosiswithpremenstrualdysphoricdisorder
AT murphylaura prevalenceoflifetimeselfinjuriousthoughtsandbehaviorsinaglobalsampleof599patientsreportingprospectivelyconfirmeddiagnosiswithpremenstrualdysphoricdisorder
AT buchertbrett prevalenceoflifetimeselfinjuriousthoughtsandbehaviorsinaglobalsampleof599patientsreportingprospectivelyconfirmeddiagnosiswithpremenstrualdysphoricdisorder
AT wagnerschumanmelissa prevalenceoflifetimeselfinjuriousthoughtsandbehaviorsinaglobalsampleof599patientsreportingprospectivelyconfirmeddiagnosiswithpremenstrualdysphoricdisorder
AT kaniaalyssa prevalenceoflifetimeselfinjuriousthoughtsandbehaviorsinaglobalsampleof599patientsreportingprospectivelyconfirmeddiagnosiswithpremenstrualdysphoricdisorder
AT rajasabina prevalenceoflifetimeselfinjuriousthoughtsandbehaviorsinaglobalsampleof599patientsreportingprospectivelyconfirmeddiagnosiswithpremenstrualdysphoricdisorder
AT milleradambryant prevalenceoflifetimeselfinjuriousthoughtsandbehaviorsinaglobalsampleof599patientsreportingprospectivelyconfirmeddiagnosiswithpremenstrualdysphoricdisorder
AT baronejordan prevalenceoflifetimeselfinjuriousthoughtsandbehaviorsinaglobalsampleof599patientsreportingprospectivelyconfirmeddiagnosiswithpremenstrualdysphoricdisorder
AT rossjaclyn prevalenceoflifetimeselfinjuriousthoughtsandbehaviorsinaglobalsampleof599patientsreportingprospectivelyconfirmeddiagnosiswithpremenstrualdysphoricdisorder